MacroGenics Ownership
| MGNX Stock | USD 1.48 0.03 2.07% |
MacroGenics | Build AI portfolio with MacroGenics Stock |
MacroGenics Stock Ownership Analysis
About 74.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MacroGenics has Price/Earnings To Growth (PEG) ratio of 0.01. The entity recorded a loss per share of 1.21. The firm had not issued any dividends in recent years. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. The company was incorporated in 2000 and is headquartered in Rockville, Maryland. Macrogenics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 427 people. To find out more about MacroGenics contact Scott MD at 301 251 5172 or learn more at https://www.macrogenics.com.MacroGenics Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MacroGenics insiders, such as employees or executives, is commonly permitted as long as it does not rely on MacroGenics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MacroGenics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MacroGenics Outstanding Bonds
MacroGenics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. MacroGenics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most MacroGenics bonds can be classified according to their maturity, which is the date when MacroGenics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MQGAU 3052 03 MAR 36 Corp BondUS556079AD36 | View | |
| MQGAU 3624 03 JUN 30 Corp BondUS556079AC52 | View | |
| MQGAU 6798 18 JAN 33 Corp BondUS556079AF83 | View | |
| MQGAU 4654 27 MAR 29 Corp BondUS55608KAN54 | View | |
| MQGAU 5033 15 JAN 30 Corp BondUS55608KAP03 | View | |
| MQGAU 3763 28 NOV 28 Corp BondUS55608KAK16 | View | |
| MQGAU 1935 14 APR 28 Corp BondUS55608KAX37 | View | |
| MQGAU 134 12 JAN 27 Corp BondUS55608KAR68 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MacroGenics Stock Analysis
When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.